As we reached the end of June last week, we review moves from smid-cap biopharma companies during the month of June. See Table 1 for...

As we reach the middle of June, we review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and...

Summary Over 40 Smid-Cap companies currently have active trials involving COVID therapeutics (this includes small molecules and...